Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Iothalamate meglumine
Drug ID BADD_D01183
Description Iothalamic acid is an iodine containing organic anion used as a diagnostic contrast agent.
Indications and Usage Conray may also be used for enhancement of computed tomographic scans performed for detection and evaluation of lesions in the liver, pancreas, kidneys, abdominal aorta, mediastinum, abdominal cavity and retroperitoneal space.
Marketing Status Prescription
ATC Code V08AA04
DrugBank ID DB09133
KEGG ID D01999
MeSH ID D007482
PubChem ID 656642
TTD Drug ID D02KCV
NDC Product Code 0019-0862; 0019-0953
Synonyms Iothalamate Meglumine | Meglumine, Iothalamate | Methylglucamine Iothalamate | Iothalamate, Methylglucamine | Iothalamic Acid Meglumine | Meglumine, Iothalamic Acid | Iotalamate Meglumine | Meglumine, Iotalamate | Methylglucamine Iotalamate | Iotalamate, Methylglucamine | Meglumine Iothalamate | Iothalamate, Meglumine | Iothalamic Acid Methylglucamine | Methylglucamine, Iothalamic Acid | Meglumine Iotalamate | Iotalamate, Meglumine | Conray 60
Chemical Information
Molecular Formula C18H26I3N3O9
CAS Registry Number 13087-53-1
SMILES CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I.CNCC(C(C(C(CO)O)O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nephropathy20.05.03.001--Not Available
Oedema08.01.07.006; 14.05.06.010--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Pain08.01.08.004--
Paraesthesia17.02.06.005--
Pruritus23.03.12.001--
Pulmonary oedema02.05.02.003; 22.01.03.003--
Rash maculo-papular23.03.13.004--
Renal failure20.01.03.005--Not Available
Seizure17.12.03.001--
Shock24.06.02.002--Not Available
Sneezing22.02.05.011--
Syncope24.06.02.012; 17.02.04.008; 02.01.02.008--
Thrombophlebitis24.01.02.001--Not Available
Thrombosis24.01.01.006--Not Available
Tremor17.01.06.002--
Urticaria23.04.02.001; 10.01.06.001--
Vasoconstriction24.04.03.008; 23.06.05.007--Not Available
Vasodilatation23.06.05.006; 24.03.02.003--Not Available
Vasospasm24.04.02.002--Not Available
Vomiting07.01.07.003--
Wheezing22.03.01.009--
Coronary artery insufficiency24.04.04.016; 02.02.01.008--Not Available
Conjunctival disorder06.06.02.004--Not Available
Cardiac fibrillation02.03.02.021--Not Available
Soft tissue necrosis24.04.02.007; 15.03.02.002--
The 2th Page    First    Pre   2    Total 2 Pages